CD28 and neoplasm: Our study of the B16.gp33 tumor model points to the fact that both CD28−CD8+ and CD28+CD8+ T cells exist in draining lymph nodes and solid tumors and that CD73-expressing CD28−CD8+ T cells can be a source of adenosine.